ES2094539T3 - Preparacion farmaceutica y procedimiento para su preparacion. - Google Patents

Preparacion farmaceutica y procedimiento para su preparacion.

Info

Publication number
ES2094539T3
ES2094539T3 ES93908973T ES93908973T ES2094539T3 ES 2094539 T3 ES2094539 T3 ES 2094539T3 ES 93908973 T ES93908973 T ES 93908973T ES 93908973 T ES93908973 T ES 93908973T ES 2094539 T3 ES2094539 T3 ES 2094539T3
Authority
ES
Spain
Prior art keywords
preparation
procedure
pharmaceutical
refers
pharmaceutical preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93908973T
Other languages
English (en)
Inventor
Juhani Posti
Kirsi Katila
Pertti Rantala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Oy
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Application granted granted Critical
Publication of ES2094539T3 publication Critical patent/ES2094539T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A UNA PREPARACION FARMACEUTICA PARA USO ORAL QUE CONTIENE COMO AGENTE ACTIVO UNA SAL FARMACOLOGICAMENTE ACEPTABLE DEL ACIDO BISFOSFONICO DE DICLOROMETILENO. SEGUN LA INVENCION LA PREPARACION ES UN DISTRIBUIDOR DE MEDICAMENTO QUE ES ENTERICO REVESTIDO CON UNA PELICULA QUE SE DISUELVE EN VALORES DE PH DE 5 A 7,2. LA INVENCION TAMBIEN SE REFIERE A UN PROCESO DE FABRICACION DE DICHA PREPARACION.
ES93908973T 1992-04-24 1993-04-21 Preparacion farmaceutica y procedimiento para su preparacion. Expired - Lifetime ES2094539T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201299A SE501389C2 (sv) 1992-04-24 1992-04-24 Farmaceutiskt preparat och förfarande för dess framställning

Publications (1)

Publication Number Publication Date
ES2094539T3 true ES2094539T3 (es) 1997-01-16

Family

ID=20386054

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93908973T Expired - Lifetime ES2094539T3 (es) 1992-04-24 1993-04-21 Preparacion farmaceutica y procedimiento para su preparacion.

Country Status (21)

Country Link
US (1) US5525354A (es)
EP (1) EP0637236B1 (es)
JP (1) JP3536106B2 (es)
AT (1) ATE143802T1 (es)
AU (1) AU671830B2 (es)
CA (1) CA2134196C (es)
CZ (1) CZ282871B6 (es)
DE (2) DE69305335T2 (es)
DK (1) DK0637236T3 (es)
EE (1) EE03107B1 (es)
ES (1) ES2094539T3 (es)
FI (1) FI110667B (es)
GR (1) GR3022249T3 (es)
HK (1) HK13097A (es)
HU (1) HU219342B (es)
IL (1) IL105403A (es)
NO (1) NO306654B1 (es)
RU (1) RU2116074C1 (es)
SE (1) SE501389C2 (es)
TW (1) TW273515B (es)
WO (1) WO1993021907A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
RU2134103C1 (ru) * 1993-05-15 1999-08-10 Берингер Маннхайм ГмбХ Таблетка с улучшенной биодоступностью биологически активного вещества и вещество, повышающее биодоступность
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
FI98343C (fi) * 1995-03-21 1997-06-10 Orion Yhtymae Oy Peroraalinen formulaatio
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
JPH11137208A (ja) * 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
EP0998932A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
EP0998933A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
WO2000050012A1 (en) * 1999-02-22 2000-08-31 Elan Corporation, Plc Solid oral dosage form containing an enhancer
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
KR20030083725A (ko) * 2001-03-01 2003-10-30 에미스페어 테크놀로지스, 인코포레이티드 비스포스포네이트 전달용 조성물
WO2002092616A1 (en) 2001-05-11 2002-11-21 Orasense, Ltd. Antisense permeation enhancers
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
ES2426445T3 (es) 2006-04-07 2013-10-23 Merrion Research Iii Limited Forma de dosificación oral sólida que contiene un potenciador
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
WO2009137080A1 (en) 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of gnrh related compounds and processes of preparation
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
US8802114B2 (en) 2011-01-07 2014-08-12 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
EP0275468B1 (de) * 1986-12-20 1991-02-06 Roche Diagnostics GmbH Clodronat-haltige Arzneimittel und Verfahren zur Herstellung derselben
JP2782691B2 (ja) * 1987-09-29 1998-08-06 ワーナー−ランバート・コンパニー 腸溶製剤の安定化
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique

Also Published As

Publication number Publication date
SE501389C2 (sv) 1995-01-30
IL105403A0 (en) 1993-08-18
GR3022249T3 (en) 1997-04-30
NO944001L (no) 1994-10-21
HU219342B (en) 2001-03-28
HK13097A (en) 1997-02-14
CZ282871B6 (cs) 1997-11-12
NO944001D0 (no) 1994-10-21
CA2134196C (en) 2004-02-10
TW273515B (es) 1996-04-01
JPH07505898A (ja) 1995-06-29
HU9403067D0 (en) 1994-12-28
DE637236T1 (de) 1995-07-06
ATE143802T1 (de) 1996-10-15
SE9201299L (sv) 1993-10-25
DK0637236T3 (da) 1997-03-17
EE03107B1 (et) 1998-08-17
SE9201299D0 (sv) 1992-04-24
DE69305335T2 (de) 1997-04-30
AU3955093A (en) 1993-11-29
IL105403A (en) 1998-03-10
RU94045950A (ru) 1996-11-10
FI944961L (fi) 1994-10-21
FI110667B (fi) 2003-03-14
EP0637236B1 (en) 1996-10-09
DE69305335D1 (de) 1996-11-14
JP3536106B2 (ja) 2004-06-07
FI944961A0 (fi) 1994-10-21
CZ261494A3 (en) 1995-02-15
RU2116074C1 (ru) 1998-07-27
CA2134196A1 (en) 1993-11-11
WO1993021907A1 (en) 1993-11-11
HUT74572A (en) 1997-01-28
US5525354A (en) 1996-06-11
EP0637236A1 (en) 1995-02-08
AU671830B2 (en) 1996-09-12
NO306654B1 (no) 1999-12-06

Similar Documents

Publication Publication Date Title
ES2094539T3 (es) Preparacion farmaceutica y procedimiento para su preparacion.
ES2074124T3 (es) Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal.
ES2159591T3 (es) Composicion de liberacion controlada.
ES2082288T3 (es) Composiciones terapeuticas para administracion intranasal de ketorolaco.
ES2067231T3 (es) Formas de dosificado para suministrar un agente antiparkinson.
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
ES2051881T3 (es) Procedimiento de preparacion de un formulacion farmaceutica de liberacion prolongada.
ES2042541T3 (es) Un procedimiento de preparacion de una formulacion farmaceutica de liberacion retardada que contiene goma de xantano.
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
NO923756L (no) Osmotisk doseringssystem for avgivelse av vaeskeformig medikament
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
ES2063146T3 (es) Composiciones farmaceuticas que contienen acido n-(3,4-dimetoxicinamoil)-antranilico.
EE03105B1 (et) Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
ES2165997T3 (es) Uso de una formulacion farmaceutica pediatrica que comprende amoxicilina y clavulanato.
BR9916114A (pt) Uso de apomorfina na fabricação de um medicamento para tratamento de disfunção erétil orgânica masculina
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES2126114T3 (es) Composiciones liquidas estables de interferon gamma.
HU9301672D0 (en) Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 19950410

FG2A Definitive protection

Ref document number: 637236

Country of ref document: ES